Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- PSIX +12.1%, SFD +3.3%
Other news:
- ALMS +12.3% (Alumis and Kaken Pharmaceutical announce licensing agreement and collaboration for ESK-001 in dermatology in Japan)
- FFAI +11.6% (secures new cash financing)
- MBLY +9% (to collaborate with Valeo (VLEEY) and Volkswagen Group (VWAGY) to enhance driver assistance in future MQB vehicles)
- DJT +8.2% (to partner with Crypto.com)
- ACIU +2.8% (Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD 2025)
- SHEL +1.9% (to present the next steps in the execution of its strategy at its Capital Markets Day)
- SNY +1.6% (announces Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis)
- TIGO +1.3% (completes delisting from Nasdaq Stockholm and SEB informs Millicom of its intent to initiate the sale of shares not withdrawn from Swedish Depositary Receipts program)
- AZN +1.1% (presents new study results reinforcing Tagrisso as the backbone therapy for EGFR-mutated lung cancer)
- CADE +1% (to complete merger with FCB Financial)